Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis

Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial

Published:2019-10 Issue:4 Volume:5 Page:205521731988876
ISSN:2055-2173
Container-title:Multiple Sclerosis Journal - Experimental, Translational and Clinical
language:en
Short-container-title:Multiple Sclerosis Journal - Experimental, Translational and Clinical

Author:

Storm-Larsen C¹²³,Myhr K-M⁴⁵,Farbu E⁴⁶,Midgard R⁷⁸,Nyquist K⁹,Broch L¹⁰,Berg-Hansen P¹¹¹,Buness A²,Holm K¹²,Ueland T¹³¹²,Fallang L-E¹³,Burum-Auensen E¹⁴,Hov JR¹²³¹⁵^ORCID,Holmøy T¹¹⁶

Affiliation:

1. Institute of Clinical Medicine, University of Oslo, Norway

2. Norwegian PSC Research Center, Oslo University Hospital, Norway

3. Research Institute of Internal Medicine, Oslo University Hospital, Norway

4. Department of Clinical Medicine, University of Bergen, Norway

5. Department of Neurology, Haukeland University Hospital, Norway

6. Neuroscience Research Group, Stavanger University Hospital, Norway

7. Department of Neurology, Molde Hospital, Norway

8. Unit for Applied Clinical Research, NTNU, Norway

9. Department of Neurology, Innlandet Hospital Trust, Norway

10. Department of Neurology, Drammen Hospital, Norway

11. Department of Neurology, Oslo University Hospital, Norway